TMEM106B and amyotrophic lateral sclerosis: A contribution of TMEM106B fibrils to disease may also present itself more as a disease modifier where the formation of TMEM106B fibrils contributes to disease manifestation, for example modifying cognitive decline in Parkinson’s disease and ALS [36, 67].